Showing 1 to 10 of 16 clinical trials
1 | 2 |
1 |
2 |
1 | 2 |
CLINICAL TRIALS Trial No ClinicalTrials.gov ID |
Phase | Coordinator | |
---|---|---|---|
A Multicenter, Double-blind, Randomized Phase 3 Study to Compare the Efficacy and Safety of Belzutifan Plus Pembrolizumab Versus Placebo Plus Pembrolizumab, in the Adjuvant Treatment of Clear Cell Renal Cell Carcinoma (ccRCC) Post Nephrectomy
MK-6482-022 NCT05239728 Recruiting |
CENTRE UNIVERSITAIRE DE SANTE MCGILL SITE GLEN |
Rodrigo Skowronski 514-934-1934 poste 36275 |
|
Surveillance of Complex Renal Cysts - The SOCRATIC Study
SOCRATIC NCT04558593 Recruiting |
CENTRE UNIVERSITAIRE DE SANTE MCGILL SITE GLEN |
Rodrigo Skowronski 514-934-1934 poste 36275 |
|
A Single Arm, Multicenter, Phase 2 Trial to Evaluate the Efficacy of Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma
The LENKYN Trial NCT04267120 Recruiting |
CHU DE QUEBEC – UNIVERSITE LAVAL L'HOTEL-DIEU DE QUEBEC ET CRCEO |
Marilyn Savard 418-525-4444 poste 20414 |
|
A Multicenter, Double-blind, Randomized Phase 3 Study to Compare the Efficacy and Safety of Belzutifan Plus Pembrolizumab Versus Placebo Plus Pembrolizumab, in the Adjuvant Treatment of Clear Cell Renal Cell Carcinoma (ccRCC) Post Nephrectomy
MK-6482-022 NCT05239728 Recruiting |
CHU DE QUEBEC – UNIVERSITE LAVAL HOPITAL DE L'ENFANT-JESUS |
Marilyn Savard 418-525-4444 poste 20414 |
|
An Open-label, Randomized Phase 3 Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or MK-1308A in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, as First-Line Treatment in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
MK-6482-012 NCT04736706 Recruiting |
CHU DE QUEBEC – UNIVERSITE LAVAL L'HOTEL-DIEU DE QUEBEC ET CRCEO |
Marilyn Savard 418-525-4444 poste 20414 |
|
Proposition canadienne d’une base de données d’un système d'information du Cancer du rein
BANQUE DE DONNÉES CKCis Recruiting |
CHU DE QUEBEC – UNIVERSITE LAVAL L'HOTEL-DIEU DE QUEBEC ET CRCEO |
Marilyn Savard 418-525-4444 poste 20414 |
|
Surveillance of Complex Renal Cysts - The SOCRATIC Study
SOCRATIC NCT04558593 Recruiting |
CHU DE QUEBEC – UNIVERSITE LAVAL HOPITAL DE L'ENFANT-JESUS |
Marilyn Savard 418-525-4444 poste 20414 |
|
Surveillance of Complex Renal Cysts - The SOCRATIC Study
SOCRATIC NCT04558593 Recruiting |
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL |
Amal Nadiri 514-890-8000 poste 26074 |
|
Proposition canadienne d’une base de données d’un système d'information du Cancer du rein
Registre cancer du rein CKCis Recruiting |
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL |
Louise Rousseau 514-890-8000 poste 35732 |
|
Surveillance of Complex Renal Cysts - The SOCRATIC Study
SOCRATIC NCT04558593 Recruiting |
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX |
Audrey Lamoureux 514-252-3400 poste 6258 Samara Bloom 514-252-3400 poste 6244 |